| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008824994 |
| P356 | DOI | 10.2165/00019053-199500081-00008 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.2165/00019053-199500081-00008 |
| P698 | PubMed publication ID | 10159001 |
| P2093 | author name string | J C Javitt | |
| P2860 | cites work | Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model | Q30992263 |
| Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study. | Q33524886 | ||
| Diabetic retinopathy. Assessment of severity and progression | Q38581303 | ||
| Ophthalmologic care for persons with diabetes | Q39351759 | ||
| Discounting and health benefits | Q41120784 | ||
| Foundations of Cost-Effectiveness Analysis for Health and Medical Practices | Q41231603 | ||
| A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age. | Q43587421 | ||
| On the Discounting of Gained life-Years in Cost-Effectiveness Analysis | Q44941798 | ||
| Cost-effectiveness of the screening and treatment of diabetic retinopathy. What are the costs of underutilization? | Q45260568 | ||
| Federal Budgetary Costs of Blindness | Q50544331 | ||
| Cost-effectiveness of strategies for detecting diabetic retinopathy. | Q50547798 | ||
| Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. | Q50548540 | ||
| Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. | Q50600310 | ||
| Ophthalmic examination among adults with diagnosed diabetes mellitus. | Q50607546 | ||
| Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group | Q66905939 | ||
| Discounting health care: only a matter of timing? | Q67518429 | ||
| Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation | Q68073915 | ||
| Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy | Q69381375 | ||
| The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation | Q69407296 | ||
| The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more | Q69485368 | ||
| Cost-effectiveness of interventions to prevent or treat coronary heart disease | Q69861827 | ||
| Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group | Q69874090 | ||
| Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction | Q69920219 | ||
| The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years | Q69947099 | ||
| Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group | Q70215913 | ||
| The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years | Q70330511 | ||
| Diagnosis of diabetic eye disease | Q70376883 | ||
| Diabetes mellitus in Tecumseh, Michigan. Prevalence, incidence, and associated conditions | Q70533282 | ||
| How effective are treatments for diabetic retinopathy? | Q70570123 | ||
| Public health focus: prevention of blindness associated with diabetic retinopathy | Q70592364 | ||
| Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group | Q70666650 | ||
| Incidence of diabetes mellitus by clinical type | Q71705185 | ||
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 33-39 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | PharmacoEconomics | Q7180778 |
| P1476 | title | Cost savings associated with detection and treatment of diabetic eye disease | |
| P478 | volume | 8 Suppl 1 |
| Q30666801 | Age-related macular degeneration: cost-of-illness issues |
| Q37117469 | Clinical trials - more than an assessment of treatment effect: LXV Edward Jackson Memorial Lecture |
| Q35797240 | Interocular symmetry of abnormal multifocal electroretinograms in adolescents with diabetes and no retinopathy |
| Q38009713 | Neuroprotection in diabetic retinopathy |
| Q43219410 | Optimal wavelet transform for the detection of microaneurysms in retina photographs. |
| Q36602516 | Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS). |
| Q33363487 | Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation |
| Q35682730 | Teleophthalmology in Diabetic Retinopathy |
| Q39007482 | The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management |
| Q37138072 | The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative welcome to medicare eye evaluation among persons without diagnosed diabetes mellitus |
| Q35194580 | The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy |
| Q34660664 | The role of models within economic analysis: focus on type 2 diabetes mellitus. |
| Q34426246 | Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy |
| Q33445229 | Validation of Smartphone Based Retinal Photography for Diabetic Retinopathy Screening |
Search more.